Population Health

Coronavirus disease 2019 (COVID-19) dominated 2020. This is a look back at how the pandemic evolved and progressed through the year, which closed with the arrival of vaccines, but also continued challenges.

The identification and assessment of frailty, defined as a state of increased vulnerability to adverse health outcomes resulting from loss of physiological reserve, should become a routine aspect of diabetes care, authors of a systematic review and meta-analysis published in The Lancet Health Longevity argued.

A look at some of our most-read news coverage of the coronavirus disease 2019 (COVID-19) pandemic.

Stark realities exposed by the pandemic have led some to advocate for redirecting resources to have the most impact on vulnerable populations.

The panel was charged with deciding if the benefits of the vaccine outweighs the risks, paving the way for the possibility that immunizations could begin within days.

What people believe about health and public health, although challenged before the coronavirus disease 2019 (COVID-19) pandemic, is even more crucial now as vaccine distribution efforts could soon begin.

With leading health experts warning of a grim few months ahead as the pandemic continues to rage, and as a vaccine launch grows more imminent, this 3-part series explores the impact of existing health disparities on COVID-19 and some potential solutions.

A combination of stay-at-home orders and vape and smoke shop closures contributed to why many young adults and people under 21 years old quit or reduced vaping.

Representation of minority populations in the oncology workforce is important to educate physicians on the meaning of being culturally appropriate, and to provide culturally appropriate care.

A loosening of Missouri’s permit-to-purchase and concealed carry firearm laws may have contributed to increased rates of firearm suicides among young residents, according to a recent study published in JAMA Network Open.

The US may have inadequate testing for coronavirus disease 2019 (COVID-19); potentially 80% of new COVID-19 cases are linked to indoor venues; protection against measles and mumps is suboptimal among cancer patients.

The Trump administration finalized rules aimed at making health care pricing more visible and transparent to those with with health insurance from employers or the individual market.

A look at the special challenges of delivering cancer care in rural areas, as ASCO seeks to address this issue.

Hospitals struggle to respond adequately to the pandemic surge; enrollment is almost complete for Pfizer and BioNTech’s coronavirus disease 2019 (COVID-19) vaccine candidate trial; the CDC reports mixed results for COVID-19 mitigation behaviors.

Can a population health framework focused on a certain set of patients with chronic disease (ie, chronic kidney disease [CKD]) improve care in the primary care setting?

The use of estimated glomerular filtration rate (eGFR) equations in assessing chronic kidney disease (CKD) for Black patients may lead to underdiagnosis and undertreatment, according to a nephrologist speaking at Kidney Week.

2020 is the 25th anniversary of The American Journal of Managed Care® and the October’s issue of the journal features an interview with Dr Kavita Patel, a nonresident fellow at the Brookings Institution and a primary care physician.

Air pollution was found to be significantly associated with an increased risk of hospital admissions for several neurological disorders, including Parkinson disease, Alzheimer disease, and other dementias.

Attendees at the Academy of Managed Care Pharmacy (AMCP) Nexus 2020 meeting will hear a keynote from a surgeon who has become more visible over the past year and a half discussing what he says are “structural problems” behind the cost of US health care.

Health care organizations can help spur growth among physicians through incorporating key experiences, such as out-of-expertise skill building and cross-functional projects, in their physician leadership development programs.

The authors, from RxCrossroads by McKesson, discuss the impact of copay accumulator and maximizer programs.

A new national study is highlighting disparities in morbidity and barriers to care that face patients with chronic obstructive pulmonary disease (COPD) living in in rural areas.

The US death toll is above average for the previous 5 months; childhood obesity is on the rise among children of color and low-income families; the debate on using e-cigarettes for smoking cessation.

Temporarily halting a trial to evaluate a vaccine means we are following the rules of safety, noted Maura Abbott, PhD, AOCNP, CPNP, RN, assistant professor of nursing at the Columbia University School of Nursing.

Addressing gaps in testing and education within precision oncology can assist in improving access to patients of color and other underserved populations.

A House panel found pharmaceutical companies exponentially increased drug prices to boost profits; CDC data show an increase in alcohol-related deaths, especially among women; 4 million more Americans enroll in Medicaid.

The authors detail how population health management enables health systems to promote public health, strengthen health system resiliency, and support financial recovery during and beyond coronavirus disease 2019 (COVID-19).

The study is part of Moderna’s larger trial to find a vaccine to prevent coronavirus disease 2019, which puts older adults, who have weaker immune responses, at a higher risk of more severe illness and death.

HHS said it will send 100 million rapid COVID-19 tests to states by year’s end; CDC says teens twice as likely to get coronavirus infection than young children; several private health insurers to stop waiving telehealth copays.

The announcement comes just 6 weeks before the Supreme Court is set to hear oral arguments in Texas v Azar, upon which the future of the Affordable Care Act (ACA)—which counts among its many provisions protection for patients with preexisting conditions—hinges, and which the administration is trying to get overturned.